Insider Trades220 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Sell | PHR | David Linetsky | President, Network Solutions | 182 | $12.28 | $640.0M | -59.85% | +32.69% | $2.2K | -1.51% | — | Buy Now |
| Jul 15, 2026 | Sell | PHR | David Linetsky | President, Network Solutions | 69 | $10.76 | $640.0M | -59.85% | +32.69% | $742.44 | -0.57% | — | Buy Now |
| Jul 15, 2026 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 2,184 | $10.85 | $640.0M | -59.85% | +32.69% | $23.7K | -4.66% | 10b5-1 | Buy Now |
| Jul 6, 2026 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 1,371 | $10.84 | $640.0M | -59.85% | +32.69% | $14.9K | -5.42% | 10b5-1 | Buy Now |
| Jun 30, 2026 | Buy | PHR | Allison C Hoffman | General Counsel & Secretary | 1,265 | $8.75 | $640.0M | -59.85% | +32.69% | $11.1K | +0.80% | — | Buy Now |
| Jun 30, 2026 | Buy | PHR | Yvonne Hui | Principal Accounting Officer | 1,371 | $8.75 | $640.0M | -59.85% | +32.69% | $12.0K | +5.73% | — | Buy Now |
| May 18, 2026 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 756 | $8.82 | $640.0M | -59.85% | +32.69% | $6.7K | -1.55% | — | Buy Now |
| Apr 20, 2026 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 6,176 | $9.06 | $640.0M | -59.85% | +32.69% | $56.0K | -3.78% | — | Buy Now |
| Apr 17, 2026 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 1,327 | $9.28 | $640.0M | -59.85% | +32.69% | $12.3K | -5.11% | — | Buy Now |
| Apr 16, 2026 | Sell | PHR | David Linetsky | President, Network Solutions | 229 | $9.17 | $640.0M | -59.85% | +32.69% | $2.1K | -1.85% | — | Buy Now |
| Apr 15, 2026 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 11,373 | $9.07 | $640.0M | -59.85% | +32.69% | $103.2K | -10.30% | — | Buy Now |
| Apr 9, 2026 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 5,438 | $9.15 | $640.0M | -59.85% | +32.69% | $49.8K | -12.71% | — | Buy Now |
| Apr 9, 2026 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 9,193 | $9.15 | $640.0M | -59.85% | +32.69% | $84.1K | -5.16% | — | Buy Now |
| Apr 9, 2026 | Sell | PHR | David Linetsky | President, Network Solutions | 18,700 | $8.67 | $640.0M | -59.85% | +32.69% | $162.1K | -3.84% | 10b5-1 | Buy Now |
| Apr 9, 2026 | Sell | PHR | Evan Roberts | President, Provider Solutions | 19,626 | $9.15 | $640.0M | -59.85% | +32.69% | $179.6K | -2.28% | — | Buy Now |
| Apr 9, 2026 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 25,382 | $9.15 | $640.0M | -59.85% | +32.69% | $232.2K | -13.92% | — | Buy Now |
| Apr 9, 2026 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 29,644 | $8.62 | $640.0M | -59.85% | +32.69% | $255.6K | -7.99% | — | Buy Now |
| Apr 9, 2026 | Sell | PHR | Chaim Indig | Chief Executive Officer | 33,008 | $9.15 | $640.0M | -59.85% | +32.69% | $302.0K | -2.32% | — | Buy Now |
| Mar 25, 2026 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 3,829 | $11.26 | $640.0M | -59.85% | +32.69% | $43.1K | -2.54% | — | Buy Now |
| Mar 23, 2026 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 6,176 | $11.97 | $640.0M | -59.85% | +32.69% | $73.9K | -3.64% | 10b5-1 | Buy Now |
| Mar 18, 2026 | Sell | PHR | David Linetsky | President, Network Solutions | 107 | $11.06 | $640.0M | -59.85% | +32.69% | $1.2K | -0.96% | — | Buy Now |
| Jan 15, 2026 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 2,889 | $16.36 | $640.0M | -59.85% | +32.69% | $47.3K | -0.90% | — | Buy Now |
| Jan 15, 2026 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 5,101 | $16.36 | $640.0M | -59.85% | +32.69% | $83.5K | -1.46% | — | Buy Now |
| Jan 15, 2026 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 5,662 | $16.36 | $640.0M | -59.85% | +32.69% | $92.6K | -1.82% | — | Buy Now |
| Jan 15, 2026 | Sell | PHR | David Linetsky | President, Network Solutions | 7,781 | $16.36 | $640.0M | -59.85% | +32.69% | $127.3K | -1.69% | — | Buy Now |
| Jan 15, 2026 | Sell | PHR | Evan Roberts | President, Provider Solutions | 8,078 | $16.36 | $640.0M | -59.85% | +32.69% | $132.2K | -0.48% | — | Buy Now |
| Jan 15, 2026 | Sell | PHR | Chaim Indig | Chief Executive Officer | 12,633 | $16.36 | $640.0M | -59.85% | +32.69% | $206.7K | -0.46% | — | Buy Now |
| Jan 14, 2026 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 744 | $16.26 | $640.0M | -59.85% | +32.69% | $12.1K | -1.25% | 10b5-1 | Buy Now |
| Jan 8, 2026 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 372 | $17.47 | $640.0M | -59.85% | +32.69% | $6.5K | -1.23% | 10b5-1 | Buy Now |
| Jan 8, 2026 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 2,602 | $17.01 | $640.0M | -59.85% | +32.69% | $44.3K | -1.60% | — | Buy Now |
| Jan 8, 2026 | Sell | PHR | David Linetsky | President, Network Solutions | 6,106 | $17.01 | $640.0M | -59.85% | +32.69% | $103.8K | -2.57% | — | Buy Now |
| Jan 8, 2026 | Sell | PHR | Evan Roberts | President, Provider Solutions | 6,317 | $17.01 | $640.0M | -59.85% | +32.69% | $107.4K | -0.75% | — | Buy Now |
| Jan 8, 2026 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 6,585 | $17.01 | $640.0M | -59.85% | +32.69% | $112.0K | -3.63% | — | Buy Now |
| Jan 8, 2026 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 8,009 | $17.01 | $640.0M | -59.85% | +32.69% | $136.2K | -4.88% | — | Buy Now |
| Jan 8, 2026 | Sell | PHR | Chaim Indig | Chief Executive Officer | 8,440 | $17.01 | $640.0M | -59.85% | +32.69% | $143.5K | -0.61% | — | Buy Now |
| Dec 31, 2025 | Buy | PHR | Yvonne Hui | Principal Accounting Officer | 372 | $14.38 | $640.0M | -59.85% | +32.69% | $5.3K | +1.24% | — | Buy Now |
| Dec 31, 2025 | Buy | PHR | Allison C Hoffman | General Counsel & Secretary | 610 | $14.38 | $640.0M | -59.85% | +32.69% | $8.8K | +0.34% | — | Buy Now |
| Dec 19, 2025 | Buy | PHR | Amy Beth Vanduyn | SVP, Human Resources | 18,000 | $4.71 | $640.0M | -59.85% | +32.69% | $84.8K | +12.03% | — | Buy Now |
| Dec 17, 2025 | Sell | PHR | David Linetsky | President, Network Solutions | 94 | $16.49 | $640.0M | -59.85% | +32.69% | $1.5K | -0.95% | — | Buy Now |
| Dec 17, 2025 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 426 | $16.25 | $640.0M | -59.85% | +32.69% | $6.9K | -1.40% | 10b5-1 | Buy Now |
| Dec 17, 2025 | Buy | PHR | Evan Roberts | President, Provider Solutions | 50,000 | $5.05 | $640.0M | -59.85% | +32.69% | $252.3K | +3.04% | — | Buy Now |
| Oct 17, 2025 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 639 | $22.36 | $640.0M | -59.85% | +32.69% | $14.3K | -0.57% | — | Buy Now |
| Oct 17, 2025 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 885 | $22.36 | $640.0M | -59.85% | +32.69% | $19.8K | -0.89% | — | Buy Now |
| Oct 17, 2025 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 1,241 | $22.36 | $640.0M | -59.85% | +32.69% | $27.8K | -0.91% | — | Buy Now |
| Oct 17, 2025 | Sell | PHR | Evan Roberts | President, Provider Solutions | 1,888 | $22.36 | $640.0M | -59.85% | +32.69% | $42.2K | -0.26% | — | Buy Now |
| Oct 17, 2025 | Sell | PHR | David Linetsky | President, Network Solutions | 2,059 | $22.36 | $640.0M | -59.85% | +32.69% | $46.0K | -1.18% | — | Buy Now |
| Oct 17, 2025 | Sell | PHR | Chaim Indig | Chief Executive Officer | 3,163 | $22.36 | $640.0M | -59.85% | +32.69% | $70.7K | -0.25% | — | Buy Now |
| Oct 15, 2025 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 302 | $23.05 | $640.0M | -59.85% | +32.69% | $7.0K | -0.99% | — | Buy Now |
| Sep 18, 2025 | Sell | PHR | David Linetsky | President, Network Solutions | 93 | $23.94 | $640.0M | -59.85% | +32.69% | $2.2K | -0.93% | — | Buy Now |
| Sep 16, 2025 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 940 | $23.28 | $640.0M | -59.85% | +32.69% | $21.9K | -2.98% | — | Buy Now |
| Sep 16, 2025 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 1,762 | $23.28 | $640.0M | -59.85% | +32.69% | $41.0K | -1.54% | — | Buy Now |
| Sep 16, 2025 | Sell | PHR | David Linetsky | President, Network Solutions | 3,229 | $23.36 | $640.0M | -59.85% | +32.69% | $75.4K | -0.61% | 10b5-1 | Buy Now |
| Sep 16, 2025 | Sell | PHR | Evan Roberts | President, Provider Solutions | 3,761 | $23.28 | $640.0M | -59.85% | +32.69% | $87.6K | -0.51% | — | Buy Now |
| Sep 16, 2025 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 4,183 | $23.28 | $640.0M | -59.85% | +32.69% | $97.4K | -4.05% | — | Buy Now |
| Sep 16, 2025 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 5,192 | $23.37 | $640.0M | -59.85% | +32.69% | $121.3K | -1.85% | 10b5-1 | Buy Now |
| Sep 16, 2025 | Sell | PHR | Chaim Indig | Chief Executive Officer | 6,328 | $23.28 | $640.0M | -59.85% | +32.69% | $147.3K | -0.50% | — | Buy Now |
| Aug 27, 2025 | Sell | PHR | Evan Roberts | President, Provider Solutions | 48,547 | $32.05 | $640.0M | -59.85% | +32.69% | $1.6M | -3.23% | 10b5-1 | Buy Now |
| Aug 27, 2025 | Sell | PHR | Chaim Indig | Chief Executive Officer | 199,986 | $19.65 | $640.0M | -59.85% | +32.69% | $3.9M | +0.00% | 10b5-1 | Buy Now |
| Aug 25, 2025 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 9,583 | $30.01 | $640.0M | -59.85% | +32.69% | $287.6K | -8.98% | 10b5-1 | Buy Now |
| Aug 25, 2025 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 18,573 | $30.37 | $640.0M | -59.85% | +32.69% | $564.1K | -14.38% | 10b5-1 | Buy Now |
| Aug 22, 2025 | Sell | PHR | David Linetsky | President, Network Solutions | 17,445 | $29.73 | $640.0M | -59.85% | +32.69% | $518.7K | -9.11% | 10b5-1 | Buy Now |
| Aug 18, 2025 | Sell | PHR | David Linetsky | President, Network Solutions | 78 | $29.16 | $640.0M | -59.85% | +32.69% | $2.3K | -0.80% | — | Buy Now |
| Jul 17, 2025 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 640 | $26.89 | $640.0M | -59.85% | +32.69% | $17.2K | -0.49% | — | Buy Now |
| Jul 17, 2025 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 886 | $26.89 | $640.0M | -59.85% | +32.69% | $23.8K | -0.82% | — | Buy Now |
| Jul 17, 2025 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 1,091 | $26.51 | $640.0M | -59.85% | +32.69% | $28.9K | -1.82% | 10b5-1 | Buy Now |
| Jul 17, 2025 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 1,245 | $26.89 | $640.0M | -59.85% | +32.69% | $33.5K | -0.90% | — | Buy Now |
| Jul 17, 2025 | Sell | PHR | Evan Roberts | Chief Operating Officer | 1,892 | $26.89 | $640.0M | -59.85% | +32.69% | $50.9K | -0.24% | — | Buy Now |
| Jul 17, 2025 | Sell | PHR | David Linetsky | SVP, Network Solutions | 2,063 | $26.89 | $640.0M | -59.85% | +32.69% | $55.5K | -1.07% | — | Buy Now |
| Jul 17, 2025 | Sell | PHR | Chaim Indig | Chief Executive Officer | 3,171 | $26.89 | $640.0M | -59.85% | +32.69% | $85.3K | -0.25% | — | Buy Now |
| Jul 15, 2025 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 729 | $27.08 | $640.0M | -59.85% | +32.69% | $19.7K | -1.18% | 10b5-1 | Buy Now |
| Jul 15, 2025 | Buy | PHR | David Linetsky | President, Network Solutions | 1,500 | $26.73 | $640.0M | -59.85% | +32.69% | $40.1K | +15.50% | — | Buy Now |
| Jul 7, 2025 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 571 | $28.85 | $640.0M | -59.85% | +32.69% | $16.5K | -1.81% | 10b5-1 | Buy Now |
| Jun 30, 2025 | Buy | PHR | Allison C Hoffman | General Counsel & Secretary | 302 | $21.41 | $640.0M | -59.85% | +32.69% | $6.5K | +0.22% | — | Buy Now |
| Jun 30, 2025 | Buy | PHR | Yvonne Hui | Principal Accounting Officer | 571 | $21.41 | $640.0M | -59.85% | +32.69% | $12.2K | +1.84% | — | Buy Now |
| Jun 27, 2025 | Sell | PHR | David Linetsky | SVP, Network Solutions | 23,729 | $28.50 | $640.0M | -59.85% | +32.69% | $676.2K | -10.92% | 10b5-1 | Buy Now |
| Jun 17, 2025 | Sell | PHR | David Linetsky | SVP, Network Solutions | 109 | $25.44 | $640.0M | -59.85% | +32.69% | $2.8K | -0.55% | — | Buy Now |
| Jun 10, 2025 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 582 | $28.00 | $640.0M | -59.85% | +32.69% | $16.3K | -1.84% | 10b5-1 | Buy Now |
| Apr 21, 2025 | Sell | PHR | David Linetsky | SVP, Life Sciences | 260 | $23.04 | $640.0M | -59.85% | +32.69% | $6.0K | -2.89% | — | Buy Now |
| Apr 21, 2025 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 2,323 | $23.42 | $640.0M | -59.85% | +32.69% | $54.4K | -4.76% | 10b5-1 | Buy Now |
| Apr 16, 2025 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 624 | $23.81 | $640.0M | -59.85% | +32.69% | $14.9K | -0.48% | — | Buy Now |
| Apr 16, 2025 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 864 | $23.81 | $640.0M | -59.85% | +32.69% | $20.6K | -0.80% | — | Buy Now |
| Apr 16, 2025 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 1,213 | $23.81 | $640.0M | -59.85% | +32.69% | $28.9K | -0.87% | — | Buy Now |
| Apr 16, 2025 | Sell | PHR | Evan Roberts | Chief Operating Officer | 1,845 | $23.81 | $640.0M | -59.85% | +32.69% | $43.9K | -0.24% | — | Buy Now |
| Apr 16, 2025 | Sell | PHR | Chaim Indig | Chief Executive Officer | 3,091 | $23.81 | $640.0M | -59.85% | +32.69% | $73.6K | -0.25% | — | Buy Now |
| Apr 16, 2025 | Sell | PHR | David Linetsky | SVP, Life Sciences | 4,499 | $23.73 | $640.0M | -59.85% | +32.69% | $106.7K | -1.02% | 10b5-1 | Buy Now |
| Apr 15, 2025 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 732 | $23.82 | $640.0M | -59.85% | +32.69% | $17.4K | -1.44% | 10b5-1 | Buy Now |
| Apr 8, 2025 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 1,695 | $23.85 | $640.0M | -59.85% | +32.69% | $40.4K | -0.64% | — | Buy Now |
| Apr 8, 2025 | Sell | PHR | David Linetsky | SVP, Life Sciences | 4,192 | $23.85 | $640.0M | -59.85% | +32.69% | $100.0K | -0.90% | — | Buy Now |
| Apr 8, 2025 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 4,680 | $23.48 | $640.0M | -59.85% | +32.69% | $109.9K | -5.32% | 10b5-1 | Buy Now |
| Apr 8, 2025 | Sell | PHR | Evan Roberts | Chief Operating Officer | 7,233 | $23.85 | $640.0M | -59.85% | +32.69% | $172.5K | -0.46% | — | Buy Now |
| Apr 8, 2025 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 8,045 | $23.85 | $640.0M | -59.85% | +32.69% | $191.9K | -3.53% | — | Buy Now |
| Apr 8, 2025 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 10,720 | $23.58 | $640.0M | -59.85% | +32.69% | $252.8K | -2.44% | 10b5-1 | Buy Now |
| Apr 8, 2025 | Sell | PHR | Chaim Indig | Chief Executive Officer | 12,167 | $23.85 | $640.0M | -59.85% | +32.69% | $290.2K | -0.48% | — | Buy Now |
| Mar 26, 2025 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 1,827 | $27.46 | $640.0M | -59.85% | +32.69% | $50.2K | -1.73% | — | Buy Now |
| Mar 18, 2025 | Sell | PHR | David Linetsky | SVP, Life Sciences | 127 | $27.60 | $640.0M | -59.85% | +32.69% | $3.5K | -0.48% | — | Buy Now |
| Mar 17, 2025 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 3,496 | $25.32 | $640.0M | -59.85% | +32.69% | $88.5K | -2.45% | 10b5-1 | Buy Now |
| Feb 18, 2025 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 3,496 | $29.72 | $640.0M | -59.85% | +32.69% | $103.9K | -2.39% | 10b5-1 | Buy Now |
| Feb 18, 2025 | Sell | PHR | Evan Roberts | Chief Operating Officer | 3,696 | $30.05 | $640.0M | -59.85% | +32.69% | $111.1K | -0.25% | 10b5-1 | Buy Now |
| Feb 18, 2025 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 5,867 | $30.04 | $640.0M | -59.85% | +32.69% | $176.3K | -2.71% | 10b5-1 | Buy Now |
| Feb 13, 2025 | Sell | PHR | David Linetsky | SVP, Life Sciences | 11,616 | $29.70 | $640.0M | -59.85% | +32.69% | $345.0K | -5.06% | 10b5-1 | Buy Now |
| Feb 13, 2025 | Sell | PHR | Evan Roberts | Chief Operating Officer | 19,591 | $30.02 | $640.0M | -59.85% | +32.69% | $588.2K | -1.30% | 10b5-1 | Buy Now |
| Feb 13, 2025 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 33,648 | $30.01 | $640.0M | -59.85% | +32.69% | $1.0M | -12.89% | 10b5-1 | Buy Now |
| Feb 7, 2025 | Sell | PHR | David Linetsky | SVP, Life Sciences | 300 | $29.52 | $640.0M | -59.85% | +32.69% | $8.9K | -0.13% | 10b5-1 | Buy Now |
| Feb 5, 2025 | Sell | PHR | David Linetsky | SVP, Life Sciences | 720 | $29.50 | $640.0M | -59.85% | +32.69% | $21.2K | -0.31% | 10b5-1 | Buy Now |
| Jan 29, 2025 | Sell | PHR | David Linetsky | SVP, Life Sciences | 500 | $29.68 | $640.0M | -59.85% | +32.69% | $14.8K | -0.22% | 10b5-1 | Buy Now |
| Jan 27, 2025 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 3,475 | $27.48 | $640.0M | -59.85% | +32.69% | $95.5K | -1.49% | — | Buy Now |
| Jan 27, 2025 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 4,813 | $27.48 | $640.0M | -59.85% | +32.69% | $132.2K | -1.63% | — | Buy Now |
| Jan 27, 2025 | Sell | PHR | Evan Roberts | Chief Operating Officer | 10,716 | $27.48 | $640.0M | -59.85% | +32.69% | $294.4K | -0.69% | — | Buy Now |
| Jan 27, 2025 | Sell | PHR | David Linetsky | SVP, Life Sciences | 11,685 | $27.48 | $640.0M | -59.85% | +32.69% | $321.1K | -2.45% | — | Buy Now |
| Jan 27, 2025 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 12,791 | $27.98 | $640.0M | -59.85% | +32.69% | $357.8K | -2.75% | 10b5-1 | Buy Now |
| Jan 27, 2025 | Sell | PHR | Chaim Indig | Chief Executive Officer | 26,248 | $27.48 | $640.0M | -59.85% | +32.69% | $721.2K | -1.03% | — | Buy Now |
| Jan 24, 2025 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 127 | $28.00 | $640.0M | -59.85% | +32.69% | $3.6K | -0.49% | 10b5-1 | Buy Now |
| Jan 21, 2025 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 4,720 | $27.31 | $640.0M | -59.85% | +32.69% | $128.9K | -4.10% | — | Buy Now |
| Jan 21, 2025 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 5,827 | $27.31 | $640.0M | -59.85% | +32.69% | $159.1K | -3.95% | — | Buy Now |
| Jan 21, 2025 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 8,426 | $27.31 | $640.0M | -59.85% | +32.69% | $230.1K | -5.45% | — | Buy Now |
| Jan 21, 2025 | Sell | PHR | Evan Roberts | Chief Operating Officer | 12,749 | $27.31 | $640.0M | -59.85% | +32.69% | $348.2K | -1.66% | — | Buy Now |
| Jan 21, 2025 | Sell | PHR | David Linetsky | SVP, Life Sciences | 13,873 | $27.31 | $640.0M | -59.85% | +32.69% | $378.9K | -5.85% | — | Buy Now |
| Jan 21, 2025 | Sell | PHR | Chaim Indig | Chief Executive Officer | 21,692 | $27.31 | $640.0M | -59.85% | +32.69% | $592.4K | -1.72% | — | Buy Now |
| Jan 15, 2025 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 381 | $26.87 | $640.0M | -59.85% | +32.69% | $10.2K | -1.46% | 10b5-1 | Buy Now |
| Jan 15, 2025 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 604 | $26.98 | $640.0M | -59.85% | +32.69% | $16.3K | -0.52% | — | Buy Now |
| Jan 15, 2025 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 836 | $26.98 | $640.0M | -59.85% | +32.69% | $22.6K | -0.56% | — | Buy Now |
| Jan 15, 2025 | Sell | PHR | Evan Roberts | Chief Operating Officer | 1,785 | $26.98 | $640.0M | -59.85% | +32.69% | $48.2K | -0.23% | — | Buy Now |
| Jan 15, 2025 | Sell | PHR | David Linetsky | SVP, Life Sciences | 1,946 | $26.98 | $640.0M | -59.85% | +32.69% | $52.5K | -0.81% | — | Buy Now |
| Jan 15, 2025 | Sell | PHR | Chaim Indig | Chief Executive Officer | 2,990 | $26.98 | $640.0M | -59.85% | +32.69% | $80.7K | -0.24% | — | Buy Now |
| Jan 15, 2025 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 4,585 | $26.90 | $640.0M | -59.85% | +32.69% | $123.3K | -1.46% | 10b5-1 | Buy Now |
| Jan 14, 2025 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 362 | $26.38 | $640.0M | -59.85% | +32.69% | $9.5K | -1.37% | — | Buy Now |
| Jan 10, 2025 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 388 | $27.85 | $640.0M | -59.85% | +32.69% | $10.8K | -1.44% | 10b5-1 | Buy Now |
| Jan 8, 2025 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 288 | $28.00 | $640.0M | -59.85% | +32.69% | $8.1K | -1.06% | 10b5-1 | Buy Now |
| Jan 8, 2025 | Sell | PHR | Evan Roberts | Chief Operating Officer | 2,681 | $27.95 | $640.0M | -59.85% | +32.69% | $74.9K | -0.17% | 10b5-1 | Buy Now |
| Jan 6, 2025 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 1,311 | $26.61 | $640.0M | -59.85% | +32.69% | $34.9K | -1.12% | — | Buy Now |
| Jan 6, 2025 | Sell | PHR | David Linetsky | SVP, Life Sciences | 3,133 | $26.61 | $640.0M | -59.85% | +32.69% | $83.4K | -1.29% | — | Buy Now |
| Jan 6, 2025 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 3,195 | $26.61 | $640.0M | -59.85% | +32.69% | $85.0K | -2.11% | — | Buy Now |
| Jan 6, 2025 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 3,982 | $26.61 | $640.0M | -59.85% | +32.69% | $105.9K | -2.44% | — | Buy Now |
| Jan 6, 2025 | Sell | PHR | Chaim Indig | Chief Executive Officer | 5,375 | $26.61 | $640.0M | -59.85% | +32.69% | $143.0K | -0.42% | — | Buy Now |
| Jan 6, 2025 | Sell | PHR | Evan Roberts | Chief Operating Officer | 10,192 | $26.89 | $640.0M | -59.85% | +32.69% | $274.1K | -0.65% | 10b5-1 | Buy Now |
| Dec 31, 2024 | Buy | PHR | Allison C Hoffman | General Counsel & Secretary | 298 | $17.57 | $640.0M | -59.85% | +32.69% | $5.2K | +0.26% | — | Buy Now |
| Dec 31, 2024 | Buy | PHR | Yvonne Hui | Principal Accounting Officer | 388 | $17.57 | $640.0M | -59.85% | +32.69% | $6.8K | +1.45% | — | Buy Now |
| Dec 18, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 24 | $25.38 | $640.0M | -59.85% | +32.69% | $609.024 | -0.27% | — | Buy Now |
| Dec 18, 2024 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 3,495 | $24.88 | $640.0M | -59.85% | +32.69% | $87.0K | -2.92% | 10b5-1 | Buy Now |
| Dec 16, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 96 | $25.00 | $640.0M | -59.85% | +32.69% | $2.4K | -0.36% | — | Buy Now |
| Dec 11, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 11,853 | $24.85 | $640.0M | -59.85% | +32.69% | $294.6K | -5.92% | 10b5-1 | Buy Now |
| Dec 10, 2024 | Sell | PHR | Evan Roberts | Chief Operating Officer | 25,000 | $24.09 | $640.0M | -59.85% | +32.69% | $602.2K | -3.32% | 10b5-1 | Buy Now |
| Dec 3, 2024 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 25,447 | $20.93 | $640.0M | -59.85% | +32.69% | $532.6K | -21.40% | 10b5-1 | Buy Now |
| Oct 18, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 1,100 | $20.49 | $640.0M | -59.85% | +32.69% | $22.5K | -0.55% | 10b5-1 | Buy Now |
| Oct 15, 2024 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 624 | $21.03 | $640.0M | -59.85% | +32.69% | $13.1K | -0.52% | — | Buy Now |
| Oct 15, 2024 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 864 | $21.03 | $640.0M | -59.85% | +32.69% | $18.2K | -0.88% | — | Buy Now |
| Oct 15, 2024 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 1,212 | $21.03 | $640.0M | -59.85% | +32.69% | $25.5K | -1.00% | — | Buy Now |
| Oct 15, 2024 | Sell | PHR | Evan Roberts | Chief Operating Officer | 1,843 | $21.03 | $640.0M | -59.85% | +32.69% | $38.7K | -0.24% | — | Buy Now |
| Oct 15, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 2,011 | $21.03 | $640.0M | -59.85% | +32.69% | $42.3K | -0.99% | — | Buy Now |
| Oct 15, 2024 | Sell | PHR | Chaim Indig | Chief Executive Officer | 3,089 | $21.03 | $640.0M | -59.85% | +32.69% | $64.9K | -0.25% | — | Buy Now |
| Oct 15, 2024 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 3,214 | $20.98 | $640.0M | -59.85% | +32.69% | $67.4K | -3.79% | 10b5-1 | Buy Now |
| Sep 19, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 24 | $24.04 | $640.0M | -59.85% | +32.69% | $577.039 | -0.27% | — | Buy Now |
| Sep 17, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 97 | $24.34 | $640.0M | -59.85% | +32.69% | $2.4K | -0.53% | — | Buy Now |
| Sep 10, 2024 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 737 | $23.25 | $640.0M | -59.85% | +32.69% | $17.1K | -0.61% | — | Buy Now |
| Sep 10, 2024 | Sell | PHR | Yvonne Hui | Principal Accounting Officer | 744 | $23.25 | $640.0M | -59.85% | +32.69% | $17.3K | -2.42% | — | Buy Now |
| Sep 10, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 1,811 | $23.25 | $640.0M | -59.85% | +32.69% | $42.1K | -0.85% | — | Buy Now |
| Sep 10, 2024 | Sell | PHR | Evan Roberts | Chief Operating Officer | 3,148 | $23.25 | $640.0M | -59.85% | +32.69% | $73.2K | -0.41% | — | Buy Now |
| Sep 10, 2024 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 3,502 | $23.25 | $640.0M | -59.85% | +32.69% | $81.4K | -3.43% | — | Buy Now |
| Sep 10, 2024 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 4,694 | $23.30 | $640.0M | -59.85% | +32.69% | $109.4K | -1.89% | 10b5-1 | Buy Now |
| Sep 10, 2024 | Sell | PHR | Chaim Indig | Chief Executive Officer | 5,295 | $23.25 | $640.0M | -59.85% | +32.69% | $123.1K | -0.43% | — | Buy Now |
| Aug 26, 2024 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 14,110 | $26.03 | $640.0M | -59.85% | +32.69% | $367.2K | -10.44% | — | Buy Now |
| Jul 29, 2024 | Sell | PHR | Chaim Indig | Chief Executive Officer | 14 | $13.39 | $640.0M | -59.85% | +32.69% | $187.46 | +0.00% | 10b5-1 | Buy Now |
| Jul 16, 2024 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 374 | $23.74 | $640.0M | -59.85% | +32.69% | $8.9K | -0.31% | — | Buy Now |
| Jul 16, 2024 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 783 | $23.74 | $640.0M | -59.85% | +32.69% | $18.6K | -0.81% | — | Buy Now |
| Jul 16, 2024 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 800 | $23.74 | $640.0M | -59.85% | +32.69% | $19.0K | -0.59% | — | Buy Now |
| Jul 16, 2024 | Sell | PHR | Evan Roberts | Chief Operating Officer | 1,669 | $23.74 | $640.0M | -59.85% | +32.69% | $39.6K | -0.22% | — | Buy Now |
| Jul 16, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 1,820 | $23.74 | $640.0M | -59.85% | +32.69% | $43.2K | -0.89% | — | Buy Now |
| Jul 16, 2024 | Sell | PHR | Chaim Indig | Chief Executive Officer | 2,644 | $23.74 | $640.0M | -59.85% | +32.69% | $62.8K | -0.22% | — | Buy Now |
| Jul 15, 2024 | Buy | PHR | Yvonne Hui | Principal Accounting Officer | 13,283 | $22.84 | $640.0M | -59.85% | +32.69% | $303.4K | +28.26% | — | Buy Now |
| Jun 28, 2024 | Buy | PHR | Allison C Hoffman | General Counsel & Secretary | 292 | $18.02 | $640.0M | -59.85% | +32.69% | $5.3K | +0.22% | — | Buy Now |
| Jun 28, 2024 | Buy | PHR | Yvonne Hui | Principal Accounting Officer | 740 | $18.02 | $640.0M | -59.85% | +32.69% | $13.3K | +4.85% | — | Buy Now |
| Jun 21, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 27 | $20.24 | $640.0M | -59.85% | +32.69% | $546.386 | -0.39% | — | Buy Now |
| Jun 21, 2024 | Sell | PHR | Janet Gunzburg | Principal Accounting Officer | 114 | $20.24 | $640.0M | -59.85% | +32.69% | $2.3K | -0.33% | — | Buy Now |
| Jun 18, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 107 | $19.53 | $640.0M | -59.85% | +32.69% | $2.1K | -0.76% | — | Buy Now |
| May 1, 2024 | Sell | PHR | Janet Gunzburg | Principal Accounting Officer | 286 | $21.00 | $640.0M | -59.85% | +32.69% | $6.0K | -0.81% | — | Buy Now |
| Apr 18, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 269 | $22.85 | $640.0M | -59.85% | +32.69% | $6.1K | -3.66% | — | Buy Now |
| Apr 18, 2024 | Sell | PHR | Janet Gunzburg | Principal Accounting Officer | 912 | $22.85 | $640.0M | -59.85% | +32.69% | $20.8K | -2.52% | — | Buy Now |
| Apr 15, 2024 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 685 | $22.86 | $640.0M | -59.85% | +32.69% | $15.7K | -0.57% | — | Buy Now |
| Apr 15, 2024 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 948 | $22.86 | $640.0M | -59.85% | +32.69% | $21.7K | -0.97% | — | Buy Now |
| Apr 15, 2024 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 1,238 | $22.86 | $640.0M | -59.85% | +32.69% | $28.3K | -0.90% | — | Buy Now |
| Apr 15, 2024 | Sell | PHR | Evan Roberts | Chief Operating Officer | 2,029 | $22.86 | $640.0M | -59.85% | +32.69% | $46.4K | -0.27% | — | Buy Now |
| Apr 15, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 2,212 | $22.86 | $640.0M | -59.85% | +32.69% | $50.6K | -1.07% | — | Buy Now |
| Apr 15, 2024 | Sell | PHR | Chaim Indig | Chief Executive Officer | 3,392 | $22.86 | $640.0M | -59.85% | +32.69% | $77.5K | -0.28% | — | Buy Now |
| Apr 10, 2024 | Sell | PHR | Janet Gunzburg | Principal Accounting Officer | 2,768 | $23.10 | $640.0M | -59.85% | +32.69% | $63.9K | -7.12% | 10b5-1 | Buy Now |
| Apr 8, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 4,161 | $22.62 | $640.0M | -59.85% | +32.69% | $94.1K | -0.96% | — | Buy Now |
| Apr 8, 2024 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 7,122 | $23.05 | $640.0M | -59.85% | +32.69% | $164.1K | -1.91% | 10b5-1 | Buy Now |
| Apr 8, 2024 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 7,778 | $22.62 | $640.0M | -59.85% | +32.69% | $175.9K | -3.81% | — | Buy Now |
| Apr 8, 2024 | Buy | PHR | Evan Roberts | Chief Operating Officer | 30,508 | $6.87 | $640.0M | -59.85% | +32.69% | $209.7K | +0.73% | — | Buy Now |
| Apr 8, 2024 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 10,175 | $22.99 | $640.0M | -59.85% | +32.69% | $233.9K | -2.37% | 10b5-1 | Buy Now |
| Apr 8, 2024 | Sell | PHR | Chaim Indig | Chief Executive Officer | 12,043 | $22.62 | $640.0M | -59.85% | +32.69% | $272.4K | -0.49% | — | Buy Now |
| Mar 25, 2024 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 3,504 | $23.21 | $640.0M | -59.85% | +32.69% | $81.3K | -3.59% | — | Buy Now |
| Mar 21, 2024 | Sell | PHR | Evan Roberts | Chief Operating Officer | 25,962 | $23.52 | $640.0M | -59.85% | +32.69% | $610.7K | -1.75% | 10b5-1 | Buy Now |
| Mar 20, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 30 | $23.66 | $640.0M | -59.85% | +32.69% | $709.791 | -0.42% | — | Buy Now |
| Mar 20, 2024 | Sell | PHR | Janet Gunzburg | Principal Accounting Officer | 137 | $23.66 | $640.0M | -59.85% | +32.69% | $3.2K | -0.35% | — | Buy Now |
| Mar 19, 2024 | Sell | PHR | Janet Gunzburg | Principal Accounting Officer | 4,526 | $23.03 | $640.0M | -59.85% | +32.69% | $104.2K | -3.68% | — | Buy Now |
| Mar 18, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 448 | $23.16 | $640.0M | -59.85% | +32.69% | $10.4K | -2.97% | — | Buy Now |
| Feb 9, 2024 | Sell | PHR | Janet Gunzburg | Principal Accounting Officer | 480 | $28.00 | $640.0M | -59.85% | +32.69% | $13.4K | -1.21% | 10b5-1 | Buy Now |
| Feb 2, 2024 | Sell | PHR | Janet Gunzburg | Principal Accounting Officer | 480 | $27.00 | $640.0M | -59.85% | +32.69% | $13.0K | -1.20% | 10b5-1 | Buy Now |
| Jan 16, 2024 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 8,921 | $24.18 | $640.0M | -59.85% | +32.69% | $215.7K | -3.07% | — | Buy Now |
| Jan 16, 2024 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 10,124 | $24.16 | $640.0M | -59.85% | +32.69% | $244.6K | -4.72% | — | Buy Now |
| Jan 16, 2024 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 10,951 | $24.15 | $640.0M | -59.85% | +32.69% | $264.5K | -4.20% | — | Buy Now |
| Jan 16, 2024 | Sell | PHR | Michael J. Davidoff | SVP, Payer Business | 18,987 | $24.15 | $640.0M | -59.85% | +32.69% | $458.6K | -10.35% | — | Buy Now |
| Jan 16, 2024 | Sell | PHR | David Linetsky | SVP, Life Sciences | 32,977 | $24.15 | $640.0M | -59.85% | +32.69% | $796.4K | -6.99% | — | Buy Now |
| Jan 16, 2024 | Sell | PHR | Evan Roberts | Chief Operating Officer | 43,328 | $24.14 | $640.0M | -59.85% | +32.69% | $1.0M | -2.72% | — | Buy Now |
| Jan 16, 2024 | Sell | PHR | Chaim Indig | Chief Executive Officer | 67,517 | $24.14 | $640.0M | -59.85% | +32.69% | $1.6M | -2.63% | — | Buy Now |
| Jan 12, 2024 | Sell | PHR | Janet Gunzburg | Principal Accounting Officer | 533 | $25.27 | $640.0M | -59.85% | +32.69% | $13.5K | -0.66% | 10b5-1 | Buy Now |
| Dec 31, 2023 | Buy | PHR | Allison C Hoffman | General Counsel & Secretary | 255 | $19.68 | $640.0M | -59.85% | +32.69% | $5.0K | +0.22% | — | Buy Now |
| Dec 19, 2023 | Sell | PHR | Janet Gunzburg | Principal Accounting Officer | 118 | $23.72 | $640.0M | -59.85% | +32.69% | $2.8K | -0.29% | — | Buy Now |
| Dec 18, 2023 | Sell | PHR | David Linetsky | SVP, Life Sciences | 259 | $23.21 | $640.0M | -59.85% | +32.69% | $6.0K | -1.68% | — | Buy Now |
| Nov 1, 2023 | Sell | PHR | Janet Gunzburg | Principal Accounting Officer | 298 | $13.38 | $640.0M | -59.85% | +32.69% | $4.0K | -0.73% | — | Buy Now |
| Oct 31, 2023 | Buy | PHR | Evan Roberts | Chief Operating Officer | 30,000 | $2.03 | $640.0M | -59.85% | +32.69% | $60.9K | +3.90% | — | Buy Now |
| Oct 16, 2023 | Sell | PHR | Amy Beth Vanduyn | SVP, Human Resources | 665 | $16.61 | $640.0M | -59.85% | +32.69% | $11.0K | -0.56% | — | Buy Now |
| Oct 16, 2023 | Sell | PHR | Balaji Gandhi | Chief Financial Officer | 861 | $16.61 | $640.0M | -59.85% | +32.69% | $14.3K | -1.00% | — | Buy Now |
| Oct 16, 2023 | Sell | PHR | Michael J. Davidoff | SVP, Payer Business | 1,198 | $16.61 | $640.0M | -59.85% | +32.69% | $19.9K | -1.28% | — | Buy Now |
| Oct 16, 2023 | Sell | PHR | Allison C Hoffman | General Counsel & Secretary | 1,297 | $16.61 | $640.0M | -59.85% | +32.69% | $21.5K | -1.12% | — | Buy Now |
| Oct 16, 2023 | Sell | PHR | Evan Roberts | Chief Operating Officer | 1,971 | $16.61 | $640.0M | -59.85% | +32.69% | $32.7K | -0.26% | — | Buy Now |
| Oct 16, 2023 | Sell | PHR | David Linetsky | SVP, Life Sciences | 2,078 | $16.61 | $640.0M | -59.85% | +32.69% | $34.5K | -0.96% | — | Buy Now |
| Oct 16, 2023 | Sell | PHR | Chaim Indig | Chief Executive Officer | 3,295 | $16.61 | $640.0M | -59.85% | +32.69% | $54.7K | -0.26% | — | Buy Now |
| Sep 18, 2023 | Sell | PHR | Janet Gunzburg | Principal Accounting Officer | 125 | $19.79 | $640.0M | -59.85% | +32.69% | $2.5K | -0.30% | — | Buy Now |
| Sep 18, 2023 | Sell | PHR | David Linetsky | SVP, Life Sciences | 130 | $19.67 | $640.0M | -59.85% | +32.69% | $2.6K | -0.55% | — | Buy Now |